CLX
October 30, 2024 - AI Summary
Undervalued by 155.9% based on the discounted cash flow analysis.
Market cap | $15.17 Billion |
---|---|
Enterprise Value | $17.89 Billion |
Dividend Yield | $4.88 (3.96522304379621%) |
Earnings per Share | $2.25 |
Beta | 0.53 |
Outstanding Shares | 123,367,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 21.88 |
---|---|
PEG | -4.71 |
Price to Sales | 2.2 |
Price to Book Ratio | 123.07 |
Enterprise Value to Revenue | 2.55 |
Enterprise Value to EBIT | 11.06 |
Enterprise Value to Net Income | 25 |
Total Debt to Enterprise | 0.16 |
Debt to Equity | 109.04 |
No data
No data
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...